Table 1.
Testing Set | Validation Set1 (Serum) | Validation Set2 (Tissue) | |||
---|---|---|---|---|---|
|
|
|
|||
PDAC patients (N = 6) | Healthy controls (N = 6) | PDAC patients (N = 110) | Healthy controls (N = 100) | PDAC patients (N = 51) | |
male | 3 (50) | 5 (83) | 75 (68) | 47 (47) | 33 (64.71) |
female | 3 (50) | 1 (17) | 35 (32) | 53 (53) | 18 (35.29) |
62.3 (48-70) | 33.4 (26-42) | 63.3 (48-73) | 34.19 (21-63) | 62.88 (44-85) | |
I | 0 | Not applicable | 24 | Not applicable | 14 |
II | 1 | 36 | 16 | ||
III | 4 | 18 | 15 | ||
IV | 1 | 22 | 6 | ||
N.A. | 0 | 10 | 0 |